Design of Incentive Programs for Optimal Medication Adherence in the Presence of Observable Consumption

References

• Akan M, Ata B, Dana JD Jr (2015) Revenue management by sequential screening. J. Econom. Theory 159:728–774.Crossref, Google Scholar
• Aswani A, Shen Z-JM, Siddiq A (2018) Data-driven incentive design in the Medicare shared savings program. Preprint, submitted June 17, https://dx.doi.org/10.2139/ssrn.2808211.Google Scholar
• Attanasio O, Kugler A, Meghir C (2011) Subsidizing vocational training for disadvantaged youth in Colombia: Evidence from a randomized trial. Amer. Econom. J. Appl. Econom. 3(3):188–220.Crossref, Google Scholar
• Ayer T, Alagoz O, Stout NK, Burnside ES (2016) Heterogeneity in women’s adherence and its role in optimal breast cancer screening policies. Management Sci. 62(5):1339–1362.Link, Google Scholar
• Babiarz KS, Suen S-c, Goldhaber-Fiebert JD (2014) Tuberculosis treatment discontinuation and symptom persistence: An observational study of Bihar, India’s public care system covering >100,000,000 inhabitants. BMC Public Health 14(418):1–13.Google Scholar
• Bagchi S, Ambe G, Sathiakumar N (2010) Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. Internat. J. Preventive Medicine 1(4):223–232.Google Scholar
• Baird S, McIntosh C, Özler B (2011) Cash or condition? Evidence from a cash transfer experiment. Quart. J. Econom. 126(4):1709–1753.Crossref, Google Scholar
• Baird SJ, Garfein RS, McIntosh CT, Özler B (2012) Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: A cluster randomised trial. Lancet 379(9823):1320–1329.Crossref, Google Scholar
• Baron DP (1973) Point estimation and risk preferences. J. Amer. Statist. Assoc. 68(344):944–950.Crossref, Google Scholar
• Baron DP, Myerson RB (1982) Regulating a monopolist with unknown costs. Econometrica 50(4):911–930.Crossref, Google Scholar
• Barrera-Osorio F, Bertrand M, Linden LL, Perez-Calle F (2011) Improving the design of conditional transfer programs: Evidence from a randomized education experiment in Colombia. Amer. Econom. J. Appl. Econom. 3(2):167–195.Crossref, Google Scholar
• Bastani H, Bayati M, Braverman M, Gummadi R, Johari R (2016) Analysis of Medicare pay-for-performance contracts. Preprint, submitted September 16, https://dx.doi.org/10.2139/ssrn.2839143.Google Scholar
• Basu AK, Lal R, Srinivasan V, Staelin R (1985) Salesforce compensation plans: An agency theoretic perspective. Marketing Sci. 4(4):267–291.Link, Google Scholar
• Beith BA, Eichler R, Weil D (2007) Performance-based incentives for health: A way to improve tuberculosis detection and treatment completion? Technical report, Center of Global Development, Washington, DC, and London, UK.Google Scholar
• Bernard CL, Owens DK, Goldhaber-Fiebert JD, Brandeau L (2017) Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis. PLoS Medicine 14(5):1–19.Crossref, Google Scholar
• Bilger M, Wong TT, Lee JY, Howard KL, Bundoc FG, Lamoureux EL, Finkelstein EA (2019) Using adherence-contingent rebates on chronic disease treatment costs to promote medication adherence: Results from a randomized controlled trial. Appl. Health Econom. Health Policy 17(6):841–855.Crossref, Google Scholar
• Boccia D, Pedrazzoli D, Wingfield T, Jaramillo E, Lönnroth K, Lewis J, Hargreaves J, Evans CA (2016) Toward cash transfer interventions for tuberculosis prevention, care and control: Key operational challenges and research priorities. BMC Infectious Diseases 16:307.Crossref, Google Scholar
• Bosworth HB (2010) Medication adherence. Bosworth HB, ed. Improving Patient Treatment Adherence (Springer, New York), 68–94.Crossref, Google Scholar
• Brandeau ML, Zaric GS, Richter A (2003) Resource allocation for control of infectious diseases in multiple independent populations: Beyond cost-effectiveness analysis. J. Health Econom. 22(4):575–598.Crossref, Google Scholar
• Buonomo B, Lacitignola D (2010) Analysis of a tuberculosis model with a case study in Uganda. J. Biological Dyamics 4(6):571–593.Google Scholar
• Cao H, Zhou Y, Song B (2011) Complex dynamics of discrete SEIS models with simple demography. Discrete Dynamics Nature Soc. 2011(4):1–21.Crossref, Google Scholar
• Centers for Disease Control and Prevention Division of Tuberculosis Elimination (2014) TB disease: Questions and answers. Accessed October 15, 2021, https://www.cdc.gov/tb/publications/faqs/qa_tbdisease.htm.Google Scholar
• Chang B (2017) Adverse selection and liquidity distortion. Rev. Econom. Stud. 85(1):275–306.Crossref, Google Scholar
• Charness G, Gneezy U (2009) Incentives to exercise. Econometrica 77(3):909–931.Crossref, Google Scholar
• Chen Q, Ayer T, Chhatwal J (2018) Optimal M-switch surveillance policies for liver cancer in a hepatitis C–infected population. Oper. Res. 66(3):673–696.Link, Google Scholar
• Chew SH, Epstein LG, Segal U (1991) Mixture symmetry and quadratic utility. Econometrica 59(1):139–163.Crossref, Google Scholar
• Chick SE, Hasija S, Nasiry J (2017) Information elicitation and influenza vaccine production. Oper. Res. 65(1):75–96.Link, Google Scholar
• Chua APG, Lim LKY, Ng H, Chee CBE, Wang YT (2015) Outcome of a grocery voucher incentive scheme for low-income tuberculosis patients on directly observed therapy in Singapore. Singapore Medical J. 56(5):274–279.Crossref, Google Scholar
• Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, Vandenbergh R, Kumar AM, Decolombani P (2014) Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Public Health Action 4(2):S59–S63.Crossref, Google Scholar
• Comolet TM, Rakotomalala R, Rajaonarioa H (1998) Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Internat. J. Tuberculosis Lung Disease 2(11):891–897.Google Scholar
• Courtwright A, Turner AN (2010) Tuberculosis and stigmatization: Pathways and interventions. Public Health Rep. 125(4):34–42.Crossref, Google Scholar
• Courty P, Hao L (2000) Sequential screening. Rev. Econom. Stud. 67(4):697–717.Crossref, Google Scholar
• Dai T, Jerath K (2019) Salesforce contracting under uncertain demand and supply: Double moral hazard and optimality of smooth contracts. Marketing Sci. 38(5):852–870.Link, Google Scholar
• Davidson H, Schluger NW, Feldman PH, Valentine DP, Telzak EE, Laufer FN (2000) The effects of increasing incentives on adherence to tuberculosis directly observed therapy. Internat. J. Tuberculosis Lung Disease 4(9):860–865.Google Scholar
• de Janvry A, Sadoulet E (2006) Making conditional cash transfer programs more efficient: Designing for maximum effect of the conditionality. World Bank Econom. Rev. 20(1):1–29.Crossref, Google Scholar
• Deo S, Rajaram K, Rath S, Karmarkar US, Goetz MB (2015) Planning for HIV screening, testing, and care at the Veterans Health Administration. Oper. Res. 63(2):287–304.Link, Google Scholar
• Dye C, Floyd K, Gunneberg C, Hosseini M, Lönnroth K, Nathanson E, Pantoja A, et al. (2007) Global tuberculosis control. Technical report, World Health Organization, Geneva.Google Scholar
• Engineer F, Keskinocak P (2009) Catch-up scheduling for childhood vaccination. Oper. Res. 57(6):1307–1319.Link, Google Scholar
• Eső P, Szentes B (2007) Optimal information disclosure in auctions and the handicap auction. Rev. Econom. Stud. 74(3):705–731.Crossref, Google Scholar
• Fitzwater SP, Caviedes L, Gilman RH, Coronel J, LaChira D, Salazar C, Saravia JC, Reddy K, Friedland JS, Moore DAJ (2010) Prolonged infectiousness of tuberculosis patients in a directly observed therapy short course program with standardized therapy. Clinical Infectious Diseases 51(4):371–378.Crossref, Google Scholar
• Gaarder MM, Glassman A, Todd JE (2010) Conditional cash transfers and health: Unpacking the causal chain. J. Development Effectiveness 2(1):6–50.Crossref, Google Scholar
• Ghamat S, Zaric GS, Pun H (2017) Contracts to promote optimal use of optional diagnostic tests in cancer treatment. Production Oper. Management 27(12):2184–2200.Crossref, Google Scholar
• Gillon R (1994) Medical ethics: Four principles plus attention to scope. BMJ 309(6948):184–188.Crossref, Google Scholar
• Gneezy U, Meier S, Rey-Biel P (2011) When and why incentives (don’t) work to modify behavior. J. Econom. Perspect. 25(4):191–210.Crossref, Google Scholar
• Government of India Ministry of Health and Family Welfare Central TB Division (2020) India TB report 2020: National tuberculosis elimination programme annual report. Technical report, New Delhi. https://tbcindia.gov.in/showfile.php?lid=3538Google Scholar
• Green EP (2014) Payment systems in the healthcare industry: An experimental study of physician incentives. J. Econom. Behav. Organ. 106:367–378.Crossref, Google Scholar
• Grossman SJ, Hart OD (1983) An analysis of the principal-agent problem. Econometrica 51(1):7–46.Crossref, Google Scholar
• Guo P, Tang CS, Wang Y, Zhao M (2017) The impact of reimbursement policy on social welfare, revisit rate and waiting time in a public healthcare system: Fee-for-service vs. bundled payment. Preprint, submitted October 25, https://dx.doi.org/10.2139/ssrn.3058734.Google Scholar
• Gupta D, Mehrotra M (2015) Bundled payments for healthcare services: Proposer selection and information sharing. Oper. Res. 63(4):772–788.Link, Google Scholar
• Hanoch G, Levy H (1970) Efficient portfolio selection with quadratic and cubic utility. J. Bus. 43(2):181–189.Crossref, Google Scholar
• Harris M, Raviv A (1978) Some results on incentive contracts with applications to education and employment, health insurance, and law enforcement. Amer. Econom. Rev. 68(1):20–30.Google Scholar
• Herrera M, Bosch P, Najera M, Aguilera X (2013) Modeling the spread of tuberculosis in semiclosed communities. Comput. Math. Methods Medicine 2013:648291.Google Scholar
• Higgins ST, Heil SH, Dantona R, Donham R, Matthews M, Badger GJ (2007) Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction 102(2):271–281.Crossref, Google Scholar
• Hill P, Stevens W, Hill S, Bah J, Donkor S, Jallow A, Lienhardt C (2005) Risk factors for defaulting from tuberculosis treatment: A prospective cohort study of 301 cases in the Gambia. Internat. J. Tuberculosis Lung Disease 9(12):1349–1354.Google Scholar
• Holmstrom B (1982) Moral hazard in teams. Bell J. Econom. 13(2):324–340.Crossref, Google Scholar
• Hutton DW, Brandeau ML (2013) Too much of a good thing? When to stop catch-up vaccination. Medical Decision. Making 33(7):920–936.Crossref, Google Scholar
• Innes RD (1990) Limited liability and incentive contracting with ex-ante action choices. J. Econom. Theory 52(1):45–67.Crossref, Google Scholar
• Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T, Muniyandi M, Narayanan PR (2007) Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India. Indian J. Tuberculosis 54(3):130–135.Google Scholar
• Juusola JL, Brandeau ML (2015) HIV treatment and prevention: A simple model to determine optimal investment. Medical Decision Making 36(3):391–409.Crossref, Google Scholar
• Karan A, Negandhi H, Nair R, Sharma A, Tiwari R, Zodpey S (2019) Size, composition and distribution of human resource for health in India: New estimates using National Sample Survey and Registry data. BMJ Open 9(4):e025979.Crossref, Google Scholar
• Kardas P, Devine S, Golembesky A, Roberts C (2005) A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Internat. J. Antimicrobial Agents 26(2):106–113.Crossref, Google Scholar
• Keeling M, Rohani P (2007) Modeling Infectious Diseases in Humans and Animals, 1st ed. (Princeton University Press, Princeton, NJ).Google Scholar
• Kermack WO, McKendrick AG (1991) Contributions to the mathematical theory of epidemics–I. Bull. Math. Biol. 53(1–2):33–55.Google Scholar
• Kulkarni P, Akarte S, Mankeshwar R, Bhawalkar J, Banerjee A, Kulkarni A (2013) Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment. Ann. Medical Health Sci. Res. 3(1):67–74.Crossref, Google Scholar
• Laffont J-J, Martimort D (2009) The Theory of Incentives: The Principal-Agent Model (Princeton University Press, Princeton, NJ).Crossref, Google Scholar
• Laffont J-J, Tirole J (1990) Adverse selection and renegotiation in procurement. Rev. Econom. Stud. 57(4):597–625.Crossref, Google Scholar
• Lagarde M, Haines A, Palmer N (2007) Conditional cash transfers for improving uptake of health interventions in low-and middle-income countries: A systematic review. JAMA 298(16):1900–1910.Crossref, Google Scholar
• Lewis TR, Sappington DE (1989) Countervailing incentives in agency problems. J. Econom. Theory 49(2):294–313.Crossref, Google Scholar
• Liefooghe R, Michiels N, Habib S, Moran M, De Muynck A (1995) Perception and social consequences of tuberculosis: A focus group study of tuberculosis patients in Sialkot, Pakistan. Soc. Sci. Medicine 41(12):1685–1692.Crossref, Google Scholar
• Liu N, Finkelstein SR, Kruk ME, Rosenthal D (2017) When waiting to see a doctor is less irritating: Understanding patient preferences and choice behavior in appointment scheduling. Management Sci. 64(5):1975–1996.Link, Google Scholar
• Long Q, Smith H, Zhang T, Tang S, Garner P (2011) Patient medical costs for tuberculosis treatment and impact on adherence in China: A systematic review. BMC Public Health 11:393.Crossref, Google Scholar
• Lorvick J, Thompson S, Edlin BR, Kral AH, Lifson AR, Watters JK (1999) Incentives and accessibility: A pilot study to promote adherence to TB prophylaxis in a high-risk community. J. Urban Health 76(4):461–467.Crossref, Google Scholar
• Maillart LM, Ivy JS, Ransom S, Diehl K (2008) Assessing dynamic breast cancer screening policies. Oper. Res. 56(6):1411–1427.Link, Google Scholar
• Mandal S, Chadha VK, Laxminarayan R, Arinaminpathy N (2017) Counting the lives saved by DOTS in India: A model-based approach. BMC Medicine 15:47.Crossref, Google Scholar
• Marcus SC, Reilly ME, Zentgraf K, Volpp KG, Olfson M (2021) Effect of escalating and deescalating financial incentives vs usual care to improve antidepressant adherence: A pilot randomized clinical trial. JAMA Psychiatry 78(2):222–224.Crossref, Google Scholar
• Martimort D, Semenov A, Stole L (2017) A theory of contracts with limited enforcement. Rev. Econom. Stud. 84(2):816–852.Google Scholar
• Martins N, Morris P, Kelly PM (2009) Food incentives to improve completion of tuberculosis treatment: Randomised controlled trial in Dili, Timor-Leste. BMJ 339:b4248.Crossref, Google Scholar
• Maskin E, Riley J (1984) Monopoly with incomplete information. RAND J. Econom. 15(2):171–196.Crossref, Google Scholar
• Mayo Clinic (2019) Tuberculosis—Diagnosis and treatment. https://www.mayoclinic.org/diseases-conditions/tuberculosis/diagnosis-treatment/drc-20351256.Google Scholar
• Mihaescu V (2013) Increasing Treatment Adherence for TB Patients Through Incentives (Romanian Red Cross).Google Scholar
• Ministry of Health and Family Welfare (2018) Government of India revised national tuberculosis control programme. https://www.nhp.gov.in/revised-national-tuberculosis-control-programme_pg.Google Scholar
• Mirrlees JA (1971) An exploration in the theory of optimum income taxation. Rev. Econom. Stud. 38(2):175–208.Crossref, Google Scholar
• Moualeu-Ngangue DP, Röblitz DS, Ehrig R, Deuflhard P (2015) Parameter identification in a tuberculosis model for Cameroon. PLoS One 10(4):e0120607.Crossref, Google Scholar
• Mussa M, Rosen S (1978) Monopoly and product quality. J. Econom. Theory 18(2):301–317.Crossref, Google Scholar
• Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, et al. (2016) Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: Treatment of drug-susceptible tuberculosis. Clinical Infectious Diseases 63(7):e147–e195.Crossref, Google Scholar
• Negoescu DM, Bimpikis K, Brandeau ML, Iancu DA (2018) Dynamic learning of patient response types: An application to treating chronic diseases. Management Sci. 64(8):3469–3488.Link, Google Scholar
• Osterberg L, Blaschke T (2005) Adherence to medication. New England J. Medicine 353(5):487–497.Crossref, Google Scholar
• Patel AR, Campbell JR, Sadatsafavi M, Marra F, Johnston JC, Smillie K, Lester RT (2017) Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: A simulation study. BMJ Open 7(9):e015108.Crossref, Google Scholar
• Philippon T, Skreta V (2012) Optimal interventions in markets with adverse selection. Amer. Econom. Rev. 102(1):1–28.Crossref, Google Scholar
• Poblete J, Spulber D (2012) The form of incentive contracts: Agency with moral hazard, risk neutrality, and limited liability. RAND J. Econom. 43(2):215–234.Crossref, Google Scholar
• Pollak RA, Wales TJ (1978) Estimation of complete demand systems from household budget data: The linear and quadratic expenditure systems. Amer. Econom. Rev. 68(3):348–359.Google Scholar
• Radhakrishna K, Goud BR, Kasthuri A, Waghmare A, Raj T (2014) Electronic health records and information portability: A pilot study in a rural primary healthcare center in India. Perspect. Health Inform. Management 11:1b.Google Scholar
• Rajan B, Tezcan T, Seidmann A (2019) Service systems with heterogeneous customers: Investigating the effect of telemedicine on chronic care. Management Sci. 65(3):1236–1267.Link, Google Scholar
• Ranganathan M, Lagarde M (2012) Promoting healthy behaviours and improving health outcomes in low and middle income countries: A review of the impact of conditional cash transfer programmes. Preventive Medicine 55:S95–S105.Crossref, Google Scholar
• Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, et al. (2017) Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine 43(3):304–377.Crossref, Google Scholar
• Richter A, Brandeau ML, Owens DK (1999) An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users. Medical Decision Making 19(2):167–179.Crossref, Google Scholar
• Richterman A, Steer-Massaro J, Jarolimova J, Luong B (2018) Cash interventions to improve clinical outcomes for pulmonary tuberculosis: Systematic review and meta-analysis. Bull. World Health Organ. 96(7):471–483.Crossref, Google Scholar
• Rigsby MO, Rosen MI, Beauvais JE, Cramer JA, Rainey PM, O’Malley SS, Dieckhaus KD, Rounsaville BJ (2000) Cue-dose training with monetary reinforcement. J. General Internal Medicine 15(12):841–847.Crossref, Google Scholar
• Rosenthal MB, Frank RG (2006) What is the empirical basis for paying for quality in healthcare? Medical Care Res. Rev. 63(2):135–157.Crossref, Google Scholar
• Rubel O, Prasad A (2016) Dynamic incentives in sales force compensation. Marketing Sci. 35(4):676–689.Link, Google Scholar
• Ruru Y, Matasik M, Oktavian A, Senyorita R, Mirino Y, Tarigan LH, van der Werf MJ, Tiemersma E, Alisjahbana B (2018) Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia. Global Health Action 11(1):1510592.Crossref, Google Scholar
• Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, et al. (2010) Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380(9859):2129–2143.Crossref, Google Scholar
• Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, et al. (2002) Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur district, south India, 2000. Internat. J. Tuberculosis Lung Disease 6(9):780–788.Google Scholar
• Sappington D (1983) Limited liability contracts between principal and agent. J. Econom. Theory 29(1):1–21.Crossref, Google Scholar
• Schell GJ, Garcia G-GP, Lavieri MS, Sussman JB, Hayward RA (2019) Optimal coinsurance rates for a heterogeneous population under inequality and resource constraints. IISE Trans. 51(1):74–91.Crossref, Google Scholar
• Schöttner A (2017) Optimal sales force compensation in dynamic settings: Commissions vs. bonuses. Management Sci. 63(5):1529–1544.Link, Google Scholar
• Siciliani L (2009) Paying for performance and motivation crowding out. Econom. Lett. 103(2):68–71.Crossref, Google Scholar
• Sotgiu G, Centis R, D’Ambrosio L, Battista Migliori G (2015) Tuberculosis treatment and drug regimens. Cold Spring Harbor Perspect. Medicine 5(5): a017822.Crossref, Google Scholar
• Suen S-c, Brandeau ML, Goldhaber-Fiebert JD (2017) Optimal timing of drug sensitivity testing for patients on first-line tuberculosis treatment. Health Care Management Sci. 21(4):632–646.Crossref, Google Scholar
• Tirole J (1988) The Theory of Industrial Organization (MIT Press, Cambridge, MA).Google Scholar
• Tirole J (2012) Overcoming adverse selection: How public intervention can restore market functioning. Amer. Econom. Rev. 102(1):29–59.Crossref, Google Scholar
• Topkis DM (1978) Minimizing a submodular function on a lattice. Oper. Res. 26(2):305–321.Link, Google Scholar
• Trauer J, Denholm J, McBryde E (2014) Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-pacific. J. Theoretical Biol. 358:74–84.Crossref, Google Scholar
• UK National Health Service (2019) Tuberculosis (TB)—Treatment. https://www.nhs.uk/conditions/tuberculosis-tb/treatment/.Google Scholar
• Van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek A, Leib S, et al. (2016) ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis. Clinical Microbiology Infection 22:S37–S62.Crossref, Google Scholar
• Vassall A (2015) Post-2015 development agenda, India perspectives: Tuberculosis. Technical report, Copenhagen Consensus Center.Google Scholar
• Volpp K, Troxel A, Mehta S, Norton L, Zhu J, Lim R, Wang W, et al. (2017) Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction: The Heartstrong randomized clinical trial. JAMA Internal Medicine 177(8):1093–1101.Crossref, Google Scholar
• Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, et al. (2009) A randomized, controlled trial of financial incentives for smoking cessation. New England J. Medicine 360(7):699–709.Crossref, Google Scholar
• Wakadha H, Chandir S, Were EV, Rubin A, Obor D, Levine OS, Gibson DG, Odhiambo F, Laserson KF, Feikin DR (2013) The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in rural Kenya. Vaccine 31(6):987–993.Crossref, Google Scholar
• Wei X, Zou G, Yin J, Walley J, Yang H, Kliner M, Mei J (2012) Providing financial incentives to rural-to-urban tuberculosis migrants in Shanghai: An intervention study. Infectious Diseases Poverty 1(1):9.Crossref, Google Scholar
• Wilder B, Suen S-C, Tambe M (2018) Preventing Infectious Disease in Dynamic Populations Under Uncertainty (AAAI).Google Scholar
• The World Bank (2018) GDP per capita. Technical report, The World Bank, Washington, DC.Google Scholar
• World Health Organization (1999) What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2003) Adherence to long-term therapies: Evidence for action. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2010) Treatment of Tuberculosis: Guidelines for National Programmes, 4th ed. (WHO Press, Geneva).Google Scholar
• World Health Organization (2013) Global tuberculosis report 2013. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2014a) Cost-effectiveness and strategic planning (WHO-CHOICE): Cost-effectiveness thresholds. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2014b) The end TB strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2017a) Global tuberculosis report 2017. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2017b) A people-centred model of tuberculosis care: A blueprint for eastern European and central Asian countries, 1st ed. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2017c) Treatment of tuberculosis guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Technical report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2018) Global tuberculosis report 2018. Technical report, World Health Organization, Geneva.Google Scholar
• Wurie FB, Cooper V, Horne R, Hayward AC (2018) Determinants of non-adherence to treatment for tuberculosis in high-income and middle-income settings: A systematic review protocol. BMJ Open 8(1):e019287.Crossref, Google Scholar
• Yarmand H, Ivy JS, Denton B, Lloyd AL (2014) Optimal two-phase vaccine allocation to geographically different regions under uncertainty. Eur. J. Oper. Res. 233(1):208–219.Crossref, Google Scholar
• Yaylali E, Ivy JS, Uzsoy R, Samoff E, Meyer AM, Maillard M (2016) Modeling the effect of public health resources and alerting on the dynamics of pertussis spread. Health Systems (Basingstoke) 5(2):81–97.Crossref, Google Scholar
• Zoltners AA, Sinha P, Lorimer SE (2006) The Complete Guide to Sales Force Incentive Compensation: How to Design and Implement Plans That Work (Amacom Books, New York).Google Scholar